The U.S. Preventive Services Task Force (USPSTF) recently expanded recommendations for colorectal cancer screening. The task force now recommends that people at average risk for colorectal cancer begin screening at 45 years old—5 years earlier than previously recommended. Read part 3 in our 3-part blog series focused on colorectal cancer.

Each month, the Cancer Policy Institute profiles advocates who have been engaged in health advocacy. Read on to learn more about Lisa, Executive Director of Smith Center for Healing and the Arts, and her work in cancer advocacy.

Access to COVID-19 vaccines is top of mind for many people, especially those impacted by cancer. Read on to learn more about the status of these vaccines and important findings regarding COVID-19's impact on people with cancer.

Each month, the Cancer Policy Institute profiles advocates who have been engaged in health advocacy. This month, for National Minority Health Month, we are spotlighting health equity in cancer care. Read on to learn more about this important topic from Eucharia Borden, CSC’s Senior Director of Health Equity and Clinical Services.

The U.S. Preventive Services Task Force recently expanded recommendations for lung cancer screening. The group now recommends that adults with a long history of smoking should begin getting annual low-dose CT scans at age 50—5 years earlier than previously recommended. This update will make an estimated 15 million people eligible for lung cancer screening.

March is National Colorectal Cancer Awareness Month, dedicated to encouraging patients, survivors, and caregivers to share their stories, advocate for colorectal cancer prevention, and inform others about the importance of early detection.

Each month, the Cancer Policy Institute profiles advocates who have been engaged in health advocacy. Read on to learn more about Gus and his work in cancer advocacy.

On just the second full day of the new Biden-Harris administration, First Lady Dr. Jill Biden called upon the Cancer Support Community to tell the story of people living with cancer during COVID-19.

The Henrietta Lacks Enhancing Cancer Research Act seeks to reduce barriers and increase access to participation in government-funded cancer clinical trials among communities that are traditionally underrepresented in trials. Read more about this important law and the legacy of Henrietta Lacks.